AJJ Medtech Holdings Limited (SGX:584)
Singapore
· Delayed Price · Currency is SGD 0.0020
0.00 (0.00%)
At close: Mar 12, 2025
AJJ Medtech Holdings Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -3.87 | -2.53 | -4.24 | -1.7 | -2.77 | Upgrade
|
| Depreciation & Amortization | 0.41 | 0.45 | 0.74 | 0.61 | 0.95 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -1.88 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.32 | - | - | Upgrade
|
| Stock-Based Compensation | 0.74 | - | - | - | - | Upgrade
|
| Other Operating Activities | -0.08 | -0.03 | 0.25 | -0.41 | 0.37 | Upgrade
|
| Change in Accounts Receivable | -0.18 | -0.15 | 0.24 | -0.25 | -0.52 | Upgrade
|
| Change in Inventory | -0.28 | -0.07 | -0.22 | -0.31 | -0.01 | Upgrade
|
| Change in Accounts Payable | 1.39 | 0.63 | 0.25 | -1.6 | 1.23 | Upgrade
|
| Operating Cash Flow | -1.86 | -1.79 | -3.2 | -5.54 | -0.76 | Upgrade
|
| Capital Expenditures | -0.01 | -0 | -0.04 | -0.5 | -0.41 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 9.5 | - | Upgrade
|
| Cash Acquisitions | - | 0.13 | - | - | -0.41 | Upgrade
|
| Other Investing Activities | - | 0.24 | - | -0.01 | - | Upgrade
|
| Investing Cash Flow | -0.01 | 0.37 | -0.04 | 8.99 | -0.82 | Upgrade
|
| Short-Term Debt Issued | 0.5 | 1.21 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 0.69 | 0.21 | - | - | Upgrade
|
| Total Debt Issued | 0.5 | 1.9 | 0.21 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -1.76 | Upgrade
|
| Long-Term Debt Repaid | -0.35 | -0.25 | -0.46 | -0.4 | -0.45 | Upgrade
|
| Total Debt Repaid | -0.35 | -0.25 | -0.46 | -0.4 | -2.21 | Upgrade
|
| Net Debt Issued (Repaid) | 0.15 | 1.66 | -0.26 | -0.4 | -2.21 | Upgrade
|
| Issuance of Common Stock | 1.32 | - | - | - | 4.46 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.07 | Upgrade
|
| Financing Cash Flow | 1.47 | 1.66 | -0.26 | -0.4 | 2.19 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0 | -0 | 0 | 0 | Upgrade
|
| Net Cash Flow | -0.4 | 0.24 | -3.5 | 3.05 | 0.62 | Upgrade
|
| Free Cash Flow | -1.87 | -1.79 | -3.24 | -6.04 | -1.17 | Upgrade
|
| Free Cash Flow Margin | -80.41% | -110.71% | -543.29% | -1894.67% | -171.60% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.05 | 0.07 | 0.08 | 0.1 | Upgrade
|
| Cash Income Tax Paid | - | - | 0 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.43 | -1.05 | -1.64 | 2.75 | -7.01 | Upgrade
|
| Unlevered Free Cash Flow | -0.4 | -1.01 | -1.61 | 2.79 | -6.95 | Upgrade
|
| Change in Net Working Capital | -0.84 | -0.14 | -0.12 | -5.13 | 5.75 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.